THE OHIO STATE UNIVERSITY HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $30.8M
- Transactions
- 2,070
- Companies
- 40
- Average per transaction
- $14,872
Who reported the payments
| Pharmacyclics LLC, An Abbvie Company | $8,064,648 |
| AstraZeneca | $5,510,322 |
| AbbVie | $4,689,203 |
| Acerta Pharma LLC | $1,915,544 |
| Intuitive Surgical | $1,641,697 |
| Dexcom, Inc. | $1,010,573 |
| Takeda Pharmaceuticals U.S.A., Inc. | $732,478 |
| Mauna Kea Technologies, Inc. | $460,000 |
| Seagen Inc. | $430,391 |
| Incyte Corporation | $430,291 |
| Philips North America LLC | $277,023 |
| Ipsen Biopharmaceuticals, Inc | $275,450 |
| Biofire Diagnostics, LLC | $270,811 |
| Verastem, Inc. | $249,011 |
| Intercept Pharmaceuticals, Inc. | $235,355 |
| Heron Therapeutics, Inc. | $212,965 |
| Pfizer | $212,671 |
| Acutus Medical, Inc. | $199,250 |
| Servier Bioinnovation | $198,926 |
| Siemens Medical Solutions USA, Inc. | $189,994 |
| Impulse Dynamics (USA) Inc. | $176,001 |
| Astrazeneca UK Limited | $168,985 |
| Karyopharm Therapeutics Inc. | $162,222 |
| Amylyx Pharmaceuticals, Inc. | $152,464 |
| Activ Surgical, Inc. | $151,016 |
| Boehringer Ingelheim International GmbH | $124,648 |
| Sanofi US Services Inc. | $120,000 |
| SPR Therapeutics, Inc | $119,685 |
| Gynesonics, Inc. | $111,805 |
| Eisai Inc. | $104,592 |
| Aesculap Biologics, LLC | $99,815 |
| Novartis | $93,491 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | $88,092 |
| KCI USA, Inc. | $88,000 |
| Stryker | $81,622 |
| Agios Pharmaceuticals, Inc. | $74,572 |
| Olympus America Inc. | $63,442 |
| Angiodynamics, Inc. | $56,525 |
| Transmedics, Inc. | $56,394 |
| Kls-martin L.p. | $54,854 |